Amedeo Lonardo | Epatologia | Lifetime achievement Award

Published on by Invention Awards

Dr. Amedeo Lonardo | Epatologia | Lifetime Achievement Award 

Azienda Ospedaliero-Univresitaria di Modena | Italy

Dr. Amedeo Lonardo is a distinguished medical scientist and clinician, holding specializations in Gastroenterology, Pediatrics, and Internal Medicine. He is qualified as Full Professor of Gastroenterology and Associate Professor of Internal Medicine by the Italian National Examination (2017). With a prolific academic career, he has authored 279 scientific publications that have collectively received 19,170 citations as of October 2025, reflecting his enduring influence in hepatology and metabolic research. His h-index stands at 69 (Scopus) and 78 (Google Scholar and ScholarGPS), highlighting his international research impact. Dr. Lonardo currently serves as Founding Editor and Editor-in-Chief of Metabolism and Target Organ Damage (since 2021) and Editor-in-Chief of Metabolites (since 2024), and also contributes as Associate Editor for Exploration of Medicine and as a member of the editorial boards of Liver International, Digestive and Liver Disease, Advances in Therapy, Exploration of Digestive Diseases, and Exploration of Drug Science. With over 546 editorial records and 1,342 peer review contributions documented in Web of Science, he stands among the most active academic editors in his field. His work has involved collaboration with 2,572 international co-authors, underscoring his extensive global scientific network. Dr. Lonardo’s research focuses primarily on sex differences and metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD. He pioneered investigations into the influence of sex and sex hormones on fatty liver disease pathogenesis (PMIDs: 10937684, 16618516, 19347015), and expanded this domain to include endocrinological and extrahepatic implications (PMIDs: 31212642, 30084737, 30733187, 39794250, 40566760). His most influential and highly cited reviews published in The Lancet (PMID: 32828189) and Hepatology (PMID: 30924946) have shaped the modern understanding of gender-related differences in MASLD, consolidating his reputation as a global leader in hepatology and metabolic research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Weiskirchen, R., & Lonardo, A. (2025). Sex hormones and metabolic dysfunction-associated steatotic liver disease. International Journal of Molecular Sciences, 26(19), 9594.

Jamalinia, M., Zare, F., Mantovani, A., Targher, G., & Lonardo, A. (2025). Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: A meta-analysis. Diabetes, Obesity and Metabolism, 27(9), e16568.

Lonardo, A., & Weiskirchen, R. (2025). Tirzepatide in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: A novel star on the horizon? Exploration of Drug Science, 3, 1008128.

Lonardo, A., Zheng, M.-H., & Weiskirchen, R. (2025). Food insecurity is an emerging risk factor for liver disease: A scoping review. Expert Review of Gastroenterology & Hepatology, 19(9), 2545812.

Lonardo, A., & Weiskirchen, R. (2025). PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD. Exploration of Digestive Diseases, 3, 100590.

Lonardo, A., Zheng, M.-H., & Eslam, M. (2025). MASLD vs. MAFLD: A narrative review. Exploration of Digestive Diseases, 3, 100586.

Lonardo, A., Stefan, N., & Mantovani, A. (2025). Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer. Trends in Endocrinology & Metabolism, 36(7),

Weiskirchen, R., & Lonardo, A. (2025). The ovary–liver axis: Molecular science and epidemiology. International Journal of Molecular Sciences, 26(13), 6382.

Alshymaa Hassnine | Hepatology | Best Researcher Award

Published on by Invention Awards

🌟Assoc Prof Dr. Alshymaa Hassnine, Hepatology, Best Researcher Award🏆

Associate Professor at Minia university, Egypt, Egypt

Alshymaa Ahmed Mohamed Hassnine is a distinguished associate professor at the Faculty of Medicine, Minia University Hospital, Egypt. With a robust career in tropical medicine, hepatology, and gastroenterology, Dr. Hassnine has made significant contributions to clinical practice and research. Her extensive experience, particularly in managing liver and gastrointestinal diseases, underscores her expertise and dedication to her field.

Author Metrics

Scopus Profile

Dr. Hassnine is a prolific researcher with numerous publications in high-impact medical journals. Her work has been widely cited, reflecting her influence and contributions to the fields of hepatology and gastroenterology. Her research covers various critical areas, including antiviral therapy efficacy, hepatic encephalopathy management, and the impact of COVID-19 on cirrhotic patients.

  • Citations: 201 (from 200 documents)
  • Documents: 16
  • h-index: 5

Education

Dr. Hassnine earned her MBBCH degree in December 2003, graduating with honors. She completed her master’s degree in tropical medicine, hepatology, and gastroenterology in July 2008. Her doctoral thesis, supervised by Prof. Dr. Madeha Makhlouf, focused on NeuroPsychiatric profiles in HCV chronic liver disease. She received her M.D. degree in March 2016.

Research Focus

Dr. Hassnine’s research interests encompass the efficacy of antiviral therapies, safety and management of hepatic encephalopathy, complications associated with COVID-19 in cirrhotic patients, and various aspects of gastroenterology and hepatology. She is particularly focused on hepatitis C and B, liver cirrhosis, and hepatocellular carcinoma.

Professional Journey

Dr. Hassnine began her professional journey as a resident doctor in tropical medicine and gastroenterology at Minia University Hospital from March 2005 to February 2008. She became an assistant lecturer in June 2009 and was promoted to lecturer in June 2016. Since October 2022, she has been serving as an associate professor at the same institution. Throughout her career, she has been actively involved in clinical practice, teaching, and research.

Honors & Awards

Dr. Hassnine has received multiple honors and awards for her academic excellence and contributions to medical research and clinical practice. These accolades highlight her commitment to advancing medical knowledge and improving patient care in her specialized fields of tropical medicine, hepatology, and gastroenterology.

Publications Noted & Contributions

  1. Efficacy of Antiviral Therapy in Patients with Post-Hepatitis C Liver Cirrhosis: Is Hyperuricaemia a Potential Adverse Effect?
    • BMJ Open Gastroenterol.
  2. Efficacy and Safety of Sodium Benzoate as an Adjunctive Therapy in the Management of Acute Hepatic Encephalopathy.
  3. COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication?
    • Canadian Journal of Gastroenterology and Hepatology, March 2022.
  4. Lessons from COVID-19: Follow-Up of Gastro Esophageal Varices Every Two Months May Have the Same Efficacy and Safety.
    • International Journal of Hepatology & Gastroenterology.
  5. Efficacy of Early Precut Sphincterotomy, Pancreatic Duct Stent, and Rectal Indomethacin to Decrease the Risk of Post ERCP Pancreatitis.
  6. Interventional Dietary Saffron Drives Antitumor Immunity in High-Risk Colorectal Cancer IBD Patients: A Multisite Clinical Trial Study.
  7. The Prevalence of Liver Steatosis Post Liver Transplantation.
  8. Adipokine rs1501299 Gene Variant and Patient Characteristics in Relation to Metabolic-Associated Fatty Liver Disease.
  9. The Prevalence of Functional Dyspepsia Using Rome IV Questionnaire Among Chronic Kidney Disease Patients.
  10. Pentraxin 3 as a Noninvasive Biomarker of Fibrosis and Carotid Intima-Media Thickness in Patients with Metabolic Associated Fatty Liver Disease.
  11. Down-Regulation of Hepatic Expression of GHR/STAT5/IGF-1 Signaling Pathway Fosters Development and Aggressiveness of HCV-Related Hepatocellular Carcinoma: Crosstalk with Snail-1 and Type 2 Transforming Growth Factor-Beta Receptor.
  12. Clinical Study on the Efficacy of Hepatitis B Vaccination in Hepatitis C Virus-Related Chronic Liver Diseases in Egypt.
  13. Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.
  14. During the Era of Pandemic Corona Virus Disease 19, is Telemedicine Effective in the Follow-Up of Hepatitis C Virus Patients Receiving Direct Anti-Viral Therapy?
  15. Rome IV Diagnostic Criteria for Functional Gastrointestinal Disorders in Patients with Chronic Hepatitis C Virus.
  16. Colonic Mucosal Eosinophilia and Immunohistochemical Expression of COX-2 and NF-kB in Patients with Irritable Bowel Syndrome.

Research Timeline

Dr. Hassnine has been actively involved in research since her early career as a resident doctor. Over the years, her work has evolved to focus on critical areas of tropical medicine, hepatology, and gastroenterology. She continues to contribute significantly to medical research and practice through her role as an associate professor and consultant.

Collaborations and Projects

Throughout her career, Dr. Hassnine has collaborated with esteemed colleagues and institutions to advance research in hepatology and gastroenterology. She participates in multisite clinical trials and projects aimed at improving patient outcomes and understanding complex medical conditions. Her collaborative efforts have led to several impactful studies and publications in her field.